Diagnos $ADK #DGNOF Signs Memorandum of Understanding with #Essilor International

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce that it has entered into a Memorandum of Understanding (MoU) with the Instruments division of Essilor International, a subsidiary of EssilorLuxottica. Essilor International is the world’s leading ophthalmic optics company. Essilor designs, manufactures and markets a wide range of lenses and diagnostic ophthalmic instruments.

 The MoU is non-binding and forms the basis of a potential distribution agreement with Essilor International for DIAGNOS’ CARA platform for the AI-enhanced analysis of wide-field retinal images, as well as of certain specified future developments of the CARA platform for a variety of applications.

 DIAGNOS has under development multiple new applications involving AI-enhanced retinal imaging to address a growing need for general purpose pathology identification. In addition to localized retinal pathology, such as macular degeneration and glaucoma, certain retinal pathologies are also known indicators of various systemic disorders, including cardiovascular and diabetic diseases. On July 20th 2021, DIAGNOS announced a clinical trial with CommonSpirit Health Research Institute in the USA for the early detection of stroke through the inspection and analysis of the retina.

 “DIAGNOS is focused on its commercialization strategy and pursuing opportunities with potential partners. We are very pleased that our AI-based technology has attracted the attention of global eyecare sector leaders such as Essilor International and we are looking forward to our discussions with respect to a mutually beneficial potential worldwide distribution agreement. At the same time, DIAGNOS continues to invest in Research and Development, furthering the creation of our intellectual property by partnering with Quebec government programs and local university (École de Technologie Supérieure) to ensure that we stay ahead of our competition worldwide,” said Mr. André Larente, President of DIAGNOS

Triumph Gold $TIG $TIGCF Completes #Artificial #Intelligence Study at the Freegold Mountain Project, #Yukon

Triumph Gold Corp. (TSX-V: TIG | OTCMKTS: TIGCF) (“Triumph Gold” or “the Company”) is pleased to announce that it has concluded an in-depth Artificial Intelligence (“AI”) study focused on the Revenue-Nucleus Area, a large zone of gold-copper-silver-molybdenum mineralization, within their district-scale Freegold Mountain Project (“the Project”) located in Yukon, Canada (Figure 1). The Company engaged Minerva Intelligence Inc. (“Minerva”) to utilize their cutting-edge DRIVER software along with K-Means Cluster Analysis to evaluate multi-element drilling data.

Results from Minerva’s cognitive AI analysis have enhanced Triumph’s technical understanding of the Nucleus and Revenue Deposits by providing confidence in existing models and identifying unrealized controls on mineralization. Key findings are being used to guide current exploration activities at the Freegold Mountain Project, notably:

  1. At the Nucleus Deposit, DRIVER revealed new vectors to gold and copper mineralization not characterized in the current mineral resource delivering superior exploration models and a clear path forward for resource expansion,
  2. At the Revenue Deposit, DRIVER has identified under-evaluated areas at northeast and southern contacts of the diatreme providing credible drill-ready exploration targets, and
  3. In the Revenue-Nucleus Area, K-Means Cluster Analysis highlighted semi-quantitative alteration styles allowing for robust modelling and vectoring toward zones of high-grade mineralization.

“As an exploration company that embraces the application of new technology, Triumph is pleased by the depth of insight provided by Minerva,” says Jesse Halle, VP Exploration for Triumph Gold. “Having over 145,000 metres of drilling at the Freegold Mountain Project, along with a massive amount of other exploration data, Minerva’s AI engine has helped sharpen the focus of our new Technical Team.”

Brian May, Chief Geoscientist for Triumph Gold adds, “DRIVER has validated Triumph’s stratigraphic and structural interpretations in the Nucleus deposit area. Multielement overlaps will be drill-tested to further confirm our technical team’s interpretations this exploration season.”

Scott Tillman, Minerva Intelligence CEO, is excited about the results. “Our ongoing relationship with Triumph Gold is a win-win for our respective companies,” said Tillman. “Triumph’s embrace of our state-of-the-art mining and exploration software is proof-positive of the value our cognitive AI technology can bring to mining and exploration companies. Triumph’s vast amount of data made the results even better than we had expected.”

Figure 1 – Location of the Freegold Mountain Project and Triumph Gold’s 2021 Minerva Artificial Intelligence study of the Revenue-Nucleus Area.

DRIVER Software 

Minerva Intelligence DRIVER software analyzed and evaluated a comprehensive database of geochemical results compiled from multiple generations of diamond drilling in the Revenue and Nucleus Mineral Resource Deposit areas of the Freegold Mountain Project.

Cost-effective computer reasoning generated orientation data for all elements in the dataset. Further work was performed on key economic elements through automated identification of optimal (“preferred”) orientations, in both planar and linear modes. These results provided potential exploration vectors from Triumph’s database that can be used to identify exploration targets in unexplored regions outside the known resources or mineral prospects.

Additionally, Minerva’s cognitive reasoning platform compared elemental association data from hundreds of past and present mines throughout the world with that of the Revenue-Nucleus Area. Comparisons between Triumph’s resources and known deposit types serve as reliable models upon which geologists can confidently develop their exploration and/or development strategies. 

Nucleus Au-Ag-Cu Deposit

The Nucleus Au-Ag-Cu deposit is a complex deposit involving early porphyry-copper and skarn mineralization overprinted with related epithermal styles of mineralization. Triumph Gold’s technical team has recently modeled the skarn-style mineralization to be preferentially located along favourable horizons within the host Yukon-Tanana metamorphic rock package, as well as at contacts with leucogranite dikes and sills. Past geochronology shows at least some of the Au-Ag-Cu mineralization is coincident with the emplacement of east-trending quartz-feldspar porphyry dikes.

The results of DRIVER’s AI analysis were many, including an independent confirmation of the probability shell developed for the 2020 Resource Estimate which was largely based on dike orientation. The close agreement of the optimal orientation and the rigorously-defined gold shell in the deposit area provides confidence in the Resource Estimate and supports this orientation as an exploration opportunity. Minerva believes this type of agreement may soon be utilized to evaluate other metals as potential co- and by-products on a semi-quantitative basis.

An additional previously unappreciated gold orientation was identified from DRIVER’s outputs at the Nucleus deposit, this time along a northwest-trending structure. This orientation is correlated with a fault corridor and coincident dike swarm and represents an additional opportunity for proximal expansion of, and exploration around, the current resource.

The preferred orientations for copper at the Nucleus deposit area resulted in a largely bimodal distribution, which had not been previously understood. The technical team is currently working on identifying underlying reasons for this distribution, along with other vectors controlling economic mineralization.

Revenue Au-Ag-Cu-Mo-W Deposit

The Revenue Deposit consists of porphyry-copper and related epithermal mineralization within a granodiorite to quartz monzonite intrusive complex. Numerous mineralized zones have been discovered at Revenue, notably the gold-copper-silver-molybdenum-bearing Blue Sky and WAu Porphyry and Epithermal Zones and the proximal mineralized diatreme breccia. Several other mineralized centres have been identified in the Revenue deposit area, including the Guder, Revenue West, Grainger, and Keirsten Zones.

Minerva’s optimal orientation DRIVER results for gold, copper, and molybdenum delineate both the southern and the northeastern contact between the diatreme breccia and the granodiorite as primary locations for further evaluation. The DRIVER results also agree very well with the current lithologic model, providing additional confidence for the technical team’s interpretations.

K-Means Cluster Analysis

K-Means Cluster (KMC) Analysis is an unsupervised learning algorithm meant to identify relationships inherent in a dataset. Unlike supervised learning methods, it does not require labeled training data from which to practice and learn, but rather uncovers native associations within the data itself. For multi-element geochemical data, it identifies potential element assemblages present in the data. If executed carefully and with appropriate data preparation, KMC Analysis can reveal complicated patterns in the data that would otherwise be missed.

Geochemical data was analyzed and evaluated using K-Means Cluster Analysis available in ioGAS software. Clusters (or groups of data records with similar geochemistry) are defined and redefined based on minimizing the distance between the data record and the cluster centre. KMC Analysis concludes when either the change in the distance of each of the data points from the respective centres for assigned cluster approaches a minimum, or the specified number of iterations is reached. Multiple iterations were attempted on the data for both the Nucleus and Revenue Deposit areas using various elements, data transforms and/or initial analytical parameters.

Nucleus Au-Ag-Cu Deposit

K-Means Cluster Analysis and subsequent interpretation though discrimination plots suggest the numerous lithologies within the Nucleus Deposit area have been subjected to variable degrees and styles of potassic alteration. Discrimination plots suggest a small proportion of the data is potassic feldspar (K-spar) alteration, implying an underlying copper-porphyry-style signature. The plots are more suggestive of potassic alteration predominantly expressed as secondary sericite. Based on molar ratios, the most recent alteration event is interpreted to preferentially involve plagioclase (predominantly albite) and is largely independent of K-spar. These observations are consistent with mineralization stemming from the intrusion of quartz-feldspar porphyry dikes from a buried porphyry intrusion.

A large portion of the results in the Nucleus Deposit area are consistent with intrusion-related skarn-type mineralization and closely-associated sulphide mineralization. The geochemistry of these high-iron areas is consistent with the appearance of secondary Ca-rich pyroxene and clinochlore. Triumph geologists believe these results are consistent with the skarn-style mineralization observed in many areas of the deposit.

Revenue Au-Ag-Cu-Mo-W Deposit

K-Means Cluster Analysis and subsequent interpretation though discrimination plots highlight the Blue Sky porphyry and contacts of diatreme breccia as the largest zone of extensive alteration, documenting high values for Ca, K and Na. Barium (Ba) is also anomalous in this zone and extends westward towards Keirsten South Zone. These zones are largely underexplored and represent targets for future work.

Specific locations in the Revenue Deposit are flagged in the K-Means Cluster Analysis work as having been subjected to alkali alteration through Na depletion and potassium addition. Results indicate that the dominant potassic phase is K-rich muscovite with only a small subset interpreted as potassium feldspar alteration. This type of alteration is consistent with the ‘low sulphidation’ deposit model proposed for the deposit area.

Diagnos $ADK $DGNOF Announces the Opening of the #AI Assisted #Screening #Clinic at #Magrabi #Hospital with the Presence of the Undersecretary of the Ministry of #Health of #SaudiArabia

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the initial clinics at the Magrabi Hospital.

Dr. Ibrahim Al-Omar, Undersecretary of the Ministry of Health for Investment, inaugurated last Wednesday the early detection unit for diabetic retinopathy operated by DIAGNOS’ AI (Artificial Intelligence) technology at Magrabi Eye, Ear and Dental Hospital in Riyadh, the first of its kind in the Kingdom. The inauguration was attended by the executive management of the Magrabi Group represented by Mr. Mutasim Alireza, Managing Director, Dr. Tariq Al-Hamad, Regional Operations Director, Senior Retinal Consultants, Yves-Stephane Couture, Vice President of DIAGNOS and members of the management of Kanhoor Company and Bayer Pharmaceuticals.

When asked, Dr. Walid bin Abdul Rahman Al-Turki, head of the retinal departments at Magrabi Group in Riyadh, stated that the aim of this unit is to examine the largest possible number of diabetic patients who are at risk of developing retinal diseases associated with them, which unfortunately may end in a gradual complete loss of vision. It is known that the incidence of diabetes in the Kingdom is about 27% of the population, which indicates the extent of the potential risk. At the conclusion of the interview, Dr. Walid Al-Turki stated that the initiative is in its infancy, and the Magrabi Group will develop and circulate it in all branches upon completion of its review.

Magrabi Hospitals and Centers has thirty-four branches in the Middle East; Twenty-two of them are in the Kingdom in Riyadh, Jeddah, Makkah, Dammam, Khobar, Al-Ahsa, Jubail, Asir, Jazan, Madinah, and Qassim.  Magrabi Hospitals and Centers Group was established in Jeddah in 1955 as the first hospital specialized in ophthalmology, and today it is the largest specialized medical network in the region.

The event was reported by the SABQ online newspaper (sabq.org) and the link is attached:

https://mobile.sabq.org/gJxtfn

Magrabi Hospitals launches initiative for early screening for diabetic retinopathy

“We extend our best wishes to Magrabi hospitals.  We would also like to thank everyone in attendance for their time and efforts in making this project a reality. The main beneficiaries will be many thousands of diabetic patients whose vision can now be protected through this collaboration,” said André Larente, President of DIAGNOS.

Diagnos Inc. $ADK and the 3rd Largest #Optical Retailer in Costa Rica Piloting CARA and its #Telemedicine #Technology

Diagnos Inc. $ADK and the 3rd Largest #optical Retailer in Costa Rica Piloting CARA and its #telemedicine #technology

#Healthcare #diabetes #retinaldisease #AI #artificialintelligence #Hypertension #stroke #deeplearning

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of a contract with Óptica Central, the third largest optical chain store in Costa Rica for implementation of CARA across Costa Rica.

“Óptica Central, in collaboration with Aselcom, DIAGNOS’ distributor, are pleased to start screening the population across our optical stores by providing DIAGNOS’ proven AI solution for early detection of eye illnesses, such as Diabetic Retinopathy, as well as preventing blindness caused by diabetes.   There is no doubt that DIAGNOS’ experience in Costa Rica, and in other Latin American countries, has been at the forefront in proving its service with their remarkable technology,” said Mr. Jefrey Salas, CEO of Óptica Central.

“At DIAGNOS we have made our mark in different parts of the world, in collaboration with our partners and different stakeholders, where our AI technology and experience for serving patients has set the standard. We know that Diabetic Retinopathy has become the main cause of blindness worldwide occurring in patients aged 20-64 years. Costa Rica is no different from other countries, with almost 15% of its population over 20 having diabetes, with less than 11% diagnosed. At least 35% have been identified with Diabetic Retinopathy within the diabetic population and 10% are in jeopardy of having severe retinopathy that will affect their vision. Our technology is helping now, through Óptica Central, to fill this gap,” said Mr. Andre Larente, President of DIAGNOS.

About Óptica Central
Founded in July 1983, Óptica Central, located in Alajuela, has become a pioneer in the visual health service offering optics and optometry services. Since its inception, it has been contributing to the visual health of the population with affordable prices and a variety of products such as: Specialties Medical Center, 8 Service Centers / Opticians in the metropolitan area, with more than 40 stores located in national territory of Costa Rica.

About DIAGNOS
DIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical health problems based of its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (Computer Assisted Retina Analysis). CARA’s AI-based image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients. CARA has been cleared for commercialization by the following regulators: Health Canada, the FDA (USA), CE (Europe), COFEPRIS (Mexico) and Saudi FDA (Saudi Arabia).

Additional information is available at www.diagnos.com and www.sedar.com

This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Mr. André Larente, President
DIAGNOS Inc.
Tel: 450-678-8882 ext. 224